期刊文献+

急性冠脉综合征合并糖尿病患者血浆hs-CRP、NT-proBNP与心功能及预后的相关性 被引量:5

Relationship between hs-CRP, NT-pro BNP, LVEF and MACE in ACS Patients Complicated Diabetes
下载PDF
导出
摘要 目的:探讨血浆高敏C反应蛋白(hs-CRP)及B型脑钠肽(NT-pro BNP)水平与合并2型糖尿病(T2DM)的急性冠脉综合征(ACS)患者心功能及预后的相关性。方法:82例ACS,分为单纯ACS患者41例,合并T2DM患者41例;血浆hs-CRP、NT-pro BNP水平采用酶联免疫吸附法(ELISA)检测,左心室射血分数(LVEF)采用彩色超声多普勒测定,并观察3月、6月的MACE事件。结果:血浆hsCRP、NT-pro BNP水平在合并T2DM的ACS组显著高于无糖尿病(DM)组,而LVEF显著低于单纯ACS组,两组间比较差异有统计学意义(P<0.05);血浆hs-CRP、NT-pro BNP水平与LVEF呈负相关(P<0.05),与3月MACE事件呈正相关。结论:血浆hs-CRP和NT-pro BNP水平对于评价合并DM的ACS患者的心功能有一定的意义,可以预测近期预后。 Objective: To investigate the relationship between high-sensitivity C-reactive protein(hs-CRP) or aminoterminal pro-brain natriuretic peptide(NT-pro BNP)and left ventricular ejection fraction(LVEF) in acute coronary syndrome(ACS) patients complicated type 2 diabetes. Methods: Serum levels of hs-CRP,NT-pro BNP at baseline were analyzed and LVEF were measured by colored doppler echocardiograph in 41 cases of simple ACS and in 41 cases of ACS complicated type 2 diabetes,and observed the MACE of all patients in 6 month. Results: In the group of ACS complicated type 2 diabetes, LVEF was lower significantly than those in the group of simple ACS,The difference was statistically significant as follows: The analysis showed that hs-CRP or NTpro BNP were related negatively to LVEF(P〈0.05) and the MACE of 3 month(P〈0.05). Conclusions:The changes of plasma hsCRP and NT-pro BNP are significant in the evaluation of left ventricular function in ACS patients complicated DM,and can predict the prognosis of the near future.
出处 《中国医药导刊》 2014年第11期1371-1372,共2页 Chinese Journal of Medicinal Guide
关键词 急性冠脉综合征 糖尿病 高敏C反应蛋白 脑钠肽 左室射血分数 ACS Diabetes High-sensitivity C-reactive protein Aminoterminal pro-brain natriuretic peptide Left ventricular ejection fraction
  • 相关文献

参考文献11

  • 1高润霖,杨新春,李延辉.急性冠脉综合征.北京:人民卫生出版社,2009:5-6. 被引量:3
  • 2Rivera JJ,Nasir K,Choi EK,et al.Detection of occult coronary artery disease in asymptomatic individuals with diabetes mellitus using non-invasive cardiac angiography [J].Atherosclerosis, 2009;203(2):442-448. 被引量:1
  • 3Jsrolim P, Serum biomarkers for heart failure E[J],Cardiovasc Pathol,2006; 15:144-149. 被引量:1
  • 4汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 5Burke AP, Traey RP, Kolodgie F, et aI.Elevated C- react ive protein values and atheroselerosis in sudden coronary death: association with different pathologies[J].Circulation,2002;105:2019-2023. 被引量:1
  • 6Monetti MI, Canavesi M, Camera M ,et al. Anti atherothrombotic and anti inflammatory properties of rosuvastatin in apoe deficient mice [J].Pharmacol Res, 2007;55(5):441-449. 被引量:1
  • 7Palazzuoli A, Caputo M, Fineschi M,et al.B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevationeoronary syndromes with preserved systolic funetion.Eur J Prey Cardiol,2012;19(3):366373. 被引量:1
  • 8Anand DV.Lahiri A.Lim E t ai.The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects [J]J Am Coil Cardiol, 2006;47(9): 1850 1857. 被引量:1
  • 9Kablak-Ziembicka A. Przewloeki T, Sokotowski A, et aLCarotid intima- media thickness, hs-CRP and TNF-a are independently associated with cardiovascular event risk in patients with atherosclcrotic occlusive disease[J].Atherosclerosis, 2011;214( 1): 185-190. 被引量:1
  • 10Martinez-Quintana El, Rodrlguez-Gonzflez F, Torres-Fuentes E,et aI.Torres-Fuentes E Effect of omega-3 acids on clinical evolution,plasma inflammatory biomarkers and B-type natriuretic peptide levels in patients with coronary heart disease[J].Med Clin (Bare), 2011;136(13):574-577. 被引量:1

二级参考文献11

  • 1Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department(PRIDE) study. Am J Cardiol.2005 .95 :948-954. 被引量:1
  • 2Pemberton C J, Yandle TG, Radenmker MT, et al. Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload. Am J Physiol, 1998, 275:1200-1208. 被引量:1
  • 3Mancia G. Neurohumoral activation in congestive heart failure. Am Heart J, 1990,120:1532-1537. 被引量:1
  • 4Yeo KT, Wu AH, Apple FS, et aL Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta, 2003, 338: 107-115. 被引量:1
  • 5Tsutsmoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide levels as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart J, 1999, 20:1799-1807. 被引量:1
  • 6Omland T, Aakvaag A, Bonarjee WS,et aL Plasma brain natriuretic peptide as an indicator of left ventricular systolic dysfunction and long-term survival after acute myocardial infarction: comparion with plasma atrial natriuretic peptide and N-terminal proatria natriuretic peptide. Circulation, 1996,93 : 1963-1969. 被引量:1
  • 7Mc Donagh T, Cunningham AD, Morrison CE, et al. Left ventricular dysfunction, natriuretic poptide, and mortality in an urban population. Heart,2001,86:21-26. 被引量:1
  • 8Squire IB, O'Brien RJ, Demme B, et al. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Clin Sci,2004, 107:309-316. 被引量:1
  • 9Richard MA, Nicholls GM, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin : new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation, 1998, 97 : 1921-1929. 被引量:1
  • 10Bazzino O, Fuselli JJ, Botto F, et al. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes. Eur Heart J, 2004, 25:859-866. 被引量:1

共引文献84

同被引文献21

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部